1.28
price down icon8.57%   -0.12
after-market Handel nachbörslich: 1.28
loading

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
25.14%
6.677
8.919 5.947 6.411 8.354
Operating Income/Loss
25.14%
-6.677
-8.919 -5.947 -6.411 -8.354
Income/Loss From Continuing Operations Before Tax
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Net Income/Loss
51.60%
-4.97
-10.27 -5.609 -5.976 -7.915
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
108.99%
2.4662
-27.44 29.81 29.69 28.75
Basic Earnings Per Share
85.98%
-2.02
-14.41 -0.19 -0.20 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Kapitalisierung:     |  Volumen (24h):